Addressing Post-COVID-19 Musculoskeletal Symptoms Through Telemedicine
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Telemedicine
- Sponsor
- Universidad Europea de Madrid
- Enrollment
- 62
- Locations
- 1
- Primary Endpoint
- Manual grip strength
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The purpose of the study will be to evaluate the effect of a rehabilitation program on the improvement of patients with post-COVID-19 musculoskeletal symptoms, as well as to quantify the impact of telemedicine that evaluates the evolution of pain, functionality, and quality of life.
Detailed Description
A randomized clinical trial will be conducted in 100 patients with post-COVID-19 musculoskeletal symptoms who will undergo a multicomponent rehabilitation program, together with an intervention and a follow-up using programmed telemedicine sessions. Data will be collected on the improvement of functional capacity and quality of life, in addition to assessing the evolution of musculoskeletal symptomatology, as well as pain and psychological variables. The telemedicine sessions will improve user adherence and follow-up, and the results are expected to be disseminated to the scientific community during and after the end of the study.
Investigators
Eleuterio Atanasio Sánchez Romero
Principal Investigator
Universidad Europea de Madrid
Eligibility Criteria
Inclusion Criteria
- •Need to be post-COVID-19 patients (ICU or non-ICU)
- •Musculoskeletal symptoms
- •Be of adult age (over 18 years)
Exclusion Criteria
- •Myocardial infarction
- •Uncontrolled arrhythmia
- •Recent pulmonary thromboembolism
- •Terminal illness
- •Patients undergoing lower limb unloading
- •Lower or upper limb fractures in the last three months
- •Severe pain (score greater than 7 on the VAS of 10 points)
- •Suffering from the previous pathology that causes neuromuscular weakness
- •Be younger than 18 and older than 65 years old
- •Influenced by medication that does not allow assessment of the real muscular functionality of the patient
Outcomes
Primary Outcomes
Manual grip strength
Time Frame: Change from base line and at the end of each of the six weeks
Grip strength will be measured in the affected hand and in the healthy hand (measuring the maximum grip strength). For this measurement, Handgrip strength averaging the result of three attempts with the dominant hand using a Baseline© model pear dynamometer
Assessment of exercise capacity
Time Frame: Change from base line and at the end of each of the six weeks
Exercise capacity will be measured with a six-minute walking test (6MWT), a sub-maximal exercise test which consists of the patient walking for six minutes along a 30 - meter corridor with two cones marking the distance to be covered while being given a series of cues.
COPD Assessment Test (CAT)
Time Frame: Change from base line and at the end of each of the six weeks
CAT is an eight item questionnaire to assess: cough, sputum, chest tightness, breathlessness, activity limitation, confidence leaving home, sleep and energy scored from zero to 4 in each item, zero corresponds to the least affected and 5 to the most affected
Quality of life according to Short- Form 36 Questionnaire (SF - 36)
Time Frame: Change from base line and at the end of each of the six weeks
SF - 36 is an instrument to asses health - related quality of life, this evaluates eight spheres (physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health) scored from zero to 100, where 100 is equivalent to no disability and zero is equivalent to maximum disability.
Secondary Outcomes
- Assessment of perceived pain(Change from base line and at the end of each of the six weeks)
- Beck II (Depression)(Change from base line and at the end of each of the six weeks)
- STAI (State-Trait Anxiety)(Change from base line and at the end of each of the six weeks)
- TSK (Tampa Scale for Kinesiophobia)(Change from base line and at the end of each of the six weeks)
- Dyspnea using the modified Medical Research Council dyspnea scale (mMRC)(Change from base line and at the end of each of the six weeks)